Skip to main content

Table 1 Participant recruitment numbers within each trial cohort

From: Delivering COVID-19 vaccine trials at speed: the implementation of a phase IV UK multi-centre randomised controlled trial to determine safety and immunogenicity of COVID-19 vaccines co-administered with seasonal influenza vaccines (ComFluCOV)

Influenza vaccines

Recruitment numbers per cohort

COVID-19 vaccines

ChAdOx1

BNT162b2

Trivalent, MF59C adjuvanted (65 years and over)

146

79

Cellular quadrivalent (under 65 years)

129

139

Recombinant quadrivalent (under 65 years)

128

58

  1. Note: The recruitment target for each cohort was 126
Back to article page

Trials

ISSN: 1745-6215